By RNA sequencing and TCGA analysis, we found that CTDSPL2 is a novel target gene of the tumor suppressor miR-193a-3p, which has the potential to function as an oncogenic molecule that promotes NSCLC progression. This evidence concerns the gene CTDSPL2 and neoplasm.